Prenatal diagnosis of lanosterol synthase deficiency: Fetal ultrasound findings as a window on family genetics

Eur J Med Genet. 2023 Oct;66(10):104825. doi: 10.1016/j.ejmg.2023.104825. Epub 2023 Sep 1.

Abstract

Cholesterol is essential in the brain from the earliest stages of embryonic development. Disruption of cholesterol synthesis pathways that leads to cholesterol deficiency underlies a few syndromes, including desmosterolosis and Smith-Lemli-Opitz syndrome. In both syndromes, brain anomalies can occur. The LSS gene encodes lanosterol synthase (LSS), an important enzyme in the cholesterol biosynthesis pathway. Biallelic pathogenic variants in this gene cause alopecia-intellectual disability type 4 syndrome (APMR4, MIM 618840), a rare autosomal recessive disorder. Here, we describe two new LSS variants (c.1016C > T; p. Ser339Leu and c.1522G > C; p. Gly508Arg) found in a compound heterozygous fetus diagnosed prenatally with brain abnormalities by ultrasound scanning. Two of his siblings from the same parents also harbored these variants. Both siblings had alopecia, mild intellectual disability, autism spectrum disorder, and cataracts. To the best of our knowledge, this case represents the first prenatal diagnosis of APMR4 first suspected by ultrasound. In addition, the phenotypic features of the siblings are extensive compared with those described in previous reports and include abnormal corpus callosum, cataracts, alopecia, and developmental delay.

Keywords: Congenital alopecia; Congenital cataracts; Exome sequencing; LSS pathogenic variant; Prenatal diagnosis; Ultrasound scanning.

MeSH terms

  • Alopecia / genetics
  • Autism Spectrum Disorder*
  • Cataract*
  • Cholesterol / genetics
  • Cholesterol / metabolism
  • Female
  • Humans
  • Intellectual Disability* / diagnostic imaging
  • Intellectual Disability* / genetics
  • Pregnancy
  • Prenatal Diagnosis

Substances

  • lanosterol synthase
  • Cholesterol